Maraviroc to Augment Rehabilitation Outcomes After Stroke "MAROS"


Phase 2/3 Results N/A

Summary of Purpose

After stroke, the combination of progressive skills practice in an adequate dose, exercise for fitness, and reduced sedentary time will augment motor and cognitive outcomes. Sensorimotor and cognitive improvements after stroke often reach a general plateau by approximately 12 weeks after onset, however. Drugs that might enhance learning or neural repair, as well as other molecular and synaptic adaptations that...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2018.

1 May 2018 25 May 2017 1 Jul 2019 1 Dec 2019 1 May 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available